Add
WNI to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| WNI > SEC Filings for WNI > Form 8-K on 4-Sep-2009 | All Recent SEC Filings |
4-Sep-2009
Entry into a Material Definitive Agreement, Financial Statem
On August 31, 2009, Schiff Nutrition Group, Inc., a Utah corporation and wholly-owned subsidiary of the registrant ("SNG"), entered into a Sales Agreement (the "Agreement") with Aker BioMarine Antarctic AS ("Aker BioMarine").
The Agreement provides for SNG's purchase of its requirements of the key ingredient for its MegaRedŽ product. Aker BioMarine has patents and patents pending relating to the key ingredient, and has granted SNG non-exclusive rights to market and sell the ingredient in certain classes of trade in the United States and certain other countries. Aker ASA, a Norway corporation of which Aker BioMarine is a wholly-owned subsidiary, provides a limited guarantee of certain of Aker BioMarine's supply obligations under the Agreement.
The term of the agreement extends to August 31, 2012, with automatic one-year extensions unless a party gives 6 months notice of non-renewal. The Agreement may be terminated upon a party's breach of the agreement and failure to cure the breach within a prescribed time period.
The foregoing description of the Agreement is qualified in its entirety by reference to the full text of the Agreement incorporated by reference hereto as Exhibit 10.1.
(d) Exhibits
10.1 Sales Agreement dated as of August 31, 2009 between Aker BioMarine Antarctic AS and Schiff Nutrition Group, Inc.
|
|